SFP
LABU icon

Sterling Financial Planning’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Sterling Financial Planning’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4
Closed -$8K – 386
2020
Q4 		$8K Buy
+4
New +$6.38K 0.01% 271

Other funds holding LABU

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CM
Condire Management Dallas, Texas $1.03B AUM 162.78% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Sterling Financial Planning's LABU Position: Q1 2021 in Review

Sterling Financial Planning sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2021, closing a stake of 4 shares — an estimated $8K sold.

Sterling Financial Planning first reported a position in LABU in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 28 funds tracked by Wall St. Rank hold LABU as of Q1 2021.

  • Sterling Financial Planning reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2021 after selling out during the quarter.
  • Sterling Financial Planning sold 4 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2021, an estimated $8K.
  • Sterling Financial Planning first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2020 and held it in 1 quarter.
  • Sterling Financial Planning's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $8K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2021.

Based on Sterling Financial Planning's 13F filing for Q1 2021, filed 28 Apr 2021.